- Home
- SLQT vs PHAR Comparison
SLQT vs PHAR Comparison
Compare SLQT & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- PHAR
- Stock Information
- Founded
- SLQT 1999
- PHAR 1988
- Country
- SLQT United States
- PHAR Netherlands
- Employees
- SLQT N/A
- PHAR N/A
- Industry
- SLQT Specialty Insurers
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- PHAR Health Care
- Exchange
- SLQT Nasdaq
- PHAR Nasdaq
- Market Cap
- SLQT 682.6M
- PHAR 627.5M
- IPO Year
- SLQT 2020
- PHAR N/A
- Fundamental
- Price
- SLQT $4.25
- PHAR $9.98
- Analyst Decision
- SLQT Hold
- PHAR Strong Buy
- Analyst Count
- SLQT 1
- PHAR 3
- Target Price
- SLQT $4.00
- PHAR $27.00
- AVG Volume (30 Days)
- SLQT 1.3M
- PHAR 6.0K
- Earning Date
- SLQT 02-05-2025
- PHAR 03-13-2025
- Dividend Yield
- SLQT N/A
- PHAR N/A
- EPS Growth
- SLQT N/A
- PHAR N/A
- EPS
- SLQT N/A
- PHAR N/A
- Revenue
- SLQT $1,381,309,000.00
- PHAR $285,745,000.00
- Revenue This Year
- SLQT $12.73
- PHAR $20.08
- Revenue Next Year
- SLQT $14.03
- PHAR $9.22
- P/E Ratio
- SLQT N/A
- PHAR N/A
- Revenue Growth
- SLQT 28.72
- PHAR 30.64
- 52 Week Low
- SLQT $1.03
- PHAR $6.65
- 52 Week High
- SLQT $4.55
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- SLQT 67.89
- PHAR 56.13
- Support Level
- SLQT $3.58
- PHAR $9.37
- Resistance Level
- SLQT $4.39
- PHAR $10.15
- Average True Range (ATR)
- SLQT 0.32
- PHAR 0.50
- MACD
- SLQT -0.00
- PHAR -0.09
- Stochastic Oscillator
- SLQT 71.96
- PHAR 57.53
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.